Trials / Completed
CompletedNCT04686760
Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients
Efficacy of Inhaled Nitroglycerin in Moderate to Severe Cases of COVID-19 Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 278 (actual)
- Sponsor
- University of Lahore · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
In current analysis moderate to severely ill Covid-19 infected patients will be nebulized with nitroglycerin, and they will be compared with the standard nebulization
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitroglycerin | 2 mg/ml solution of nitroglycerin used for nebulization four hourly |
Timeline
- Start date
- 2020-11-15
- Primary completion
- 2021-12-15
- Completion
- 2022-03-15
- First posted
- 2020-12-29
- Last updated
- 2022-05-18
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT04686760. Inclusion in this directory is not an endorsement.